Abstract: Using proton-proton collision data at centre-of-mass energies of root s = 7, 8 and 13 TeV recorded by the LHCb experiment at the Large Hadron Collider, corresponding to an integrated luminosity of 9 fb(-1), the invariant mass spectrum of J/psi pairs is studied. A narrow structure around 6.9 GeV/c(2) matching the line-shape of a resonance and a broad structure just above twice the J/psi mass are observed. The deviation of the data from nonresonant J/psi-pair production is above five standard deviations in the mass region between 6.2 and 7.4 GeV/c(2), covering predicted masses of states composed of four charm quarks. The mass and natural width of the narrow X(6900) structure are measured assuming a Breit-Wigner lineshape.

Abstract: The properties of the Lambda(1405) resonance are key ingredients for determining the antikaon-nucleon interaction in strangeness nuclear physics, and the novel internal structure of the Lambda(1405) is of great interest in hadron physics, as a prototype case of a baryon that does not fit into the simple three-quark picture. We show that a quantitative description of the antikaon-nucleon interaction with the Lambda(1405) is achieved in the framework of chiral SU(3) dynamics, with the help of recent experimental progress. Further constraints on the (K) over barN subthreshold interaction are provided by analyzing pi Sigma spectra in various processes, such as the K(-)d -> pi Sigma n reaction and the Lambda(c) -> pi pi Sigma decay. The structure of the Lambda(1405) is found to be dominated by an antikaon-nucleon molecular configuration, based on its wavefunction derived from a realistic (K) over barN potential and the compositeness criteria from a model-independent weak-binding relation.

Abstract: Charged particle therapy, or so-called hadrontherapy, is developing very rapidly. There is large pressure on the scientific community to deliver dedicated accelerators, providing the best possible treatment modalities at the lowest cost. In this context, the Italian research Foundation TERA is developing fast-cycling accelerators, dubbed 'cyclinacs'. These are a combination of a cyclotron (accelerating ions to a fixed initial energy) followed by a high gradient linac boosting the ions energy up to the maximum needed for medical therapy. The linac is powered by many independently controlled klystrons to vary the beam energy from one pulse to the next. This accelerator is best suited to treat moving organs with a 4D multipainting spot scanning technique. A dual proton/carbon ion cyclinac is here presented. It consists of an Electron Beam Ion Source, a superconducting isochronous cyclotron and a high-gradient linac. All these machines are pulsed at high repetition rate (100-400 Hz). The source should deliver both C6+ and H-2(+) ions in short pulses (1.5 μs flat-top) and with sufficient intensity (at least 10(8) fully stripped carbon ions per pulse at 300 Hz). The cyclotron accelerates the ions to 120 MeV/u. It features a compact design (with superconducting coils) and a low power consumption. The linac has a novel C-band high-gradient structure and accelerates the ions to variable energies up to 400 MeV/u. High RF frequencies lead to power consumptions which are much lower than the ones of synchrotrons for the same ion extraction energy. This work is part of a collaboration with the CLIC group, which is working at CERN on high-gradient electron-positron colliders.